secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2022-01-14T23:59:59+00:00
Accession:  0001493152-22-001217
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix appoints Aurora Cassirer and Maria Schroeder as independent directors
--------------------------------------------------------------------------------

- Board expands from six to eight directors; six of eight now independent under Nasdaq rules.
- Aurora Cassirer appointed to Compensation and Nominating & Governance Committees; 30-year attorney.
- Maria Schroeder appointed to Audit Committee; CPA with CFO experience at KCI and Brain Sentinel.
- Appointments effective January 13, 2022; both to serve until 2022 annual meeting.
- New directors receive compensation per non-employee director policy; no material transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315222001217/0001493152-22-001217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315222001217/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-001217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer